Literature DB >> 2974286

The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets.

P R Mayeux1, H E Morton, J Gillard, A Lord, T A Morinelli, A Boehm, D E Mais, P V Halushka.   

Abstract

Both thromboxane A2 (TXA2) and its precursor prostaglandin H2 (PGH2) are labile and share a common receptor. The affinities of these two compounds for their putative common receptor are unknown. We compared the potencies of TXA2 and PGH2 to aggregate human platelets and bind to the TXA2/PGH2 receptor. TXA2 was more potent than PGH2 in initiating aggregation in platelet-rich plasma, EC50 of 66 +/- 15 nM and 2.5 +/- 1.3 microM, respectively. In washed platelets, however, PGH2 was more potent than TXA2 with EC50 values of 45 +/- 2 nM and 163 +/- 21 nM, respectively. The affinity of these two compounds in washed platelets was determined in radioligand competition binding assays employing [125I]-PTA-OH. The Kd values for PGH2 and TXA2 were 43 nM and 125 nM, respectively. The results demonstrate that the affinity of PGH2 for the platelet TXA2/PGH2 receptor is greater than previously thought. The data raise the possibility that PGH2 may significantly contribute to the responses attributed to TXA2 in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974286     DOI: 10.1016/s0006-291x(88)80311-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  The prostaglandin transporter PGT transports PGH(2).

Authors:  Yuling Chi; Victor L Schuster
Journal:  Biochem Biophys Res Commun       Date:  2010-03-25       Impact factor: 3.575

Review 2.  Current concepts for a drug-induced inhibition of formation and action of thromboxane A2.

Authors:  H Patscheke
Journal:  Blut       Date:  1990-05

Review 3.  A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.782

Review 4.  TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus.

Authors:  Francesca Santilli; Luciana Mucci; Giovanni Davì
Journal:  Intern Emerg Med       Date:  2010-08-24       Impact factor: 3.397

5.  Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.

Authors:  J P De La Cruz; M A Villalobos; R Escalante; A Guerrero; M M Arrebola; F Sánchez de La Cuesta
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 6.  Aspirin resistance - does it clinically matter?

Authors:  Karsten Schrör; T Hohlfeld; A-A Weber
Journal:  Clin Res Cardiol       Date:  2006-08-16       Impact factor: 5.460

7.  Dietary fat modifies thromboxane A2-induced stimulation of rat platelets.

Authors:  J W Heemskerk; M A Feijge; A Kester; G Hornstra
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

Review 8.  Antiplatelet drugs. A comparative review.

Authors:  K Schrör
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

9.  Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels.

Authors:  T A Morinelli; A K Okwu; D E Mais; P V Halushka; V John; C K Chen; J Fried
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.